Infliximab as a therapy for idiopathic hypereosinophilic syndrome.
Taverna
Josephine A
JA
Boston University School of Medicine, Boston, MA 02118, USA.
Lerner
Adam
A
Goldberg
Lynne
L
Werth
Stephen
S
Demierre
Marie-France
MF
D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D000069285:Infliximab; D012871:Skin Diseases / Q000175:diagnosis / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab